FDA has expanded approval for an emergency booster dose of the COVID-19 vaccine from Pfizer-BioNTech. A second dose is approved for adults 50 years of age or older and children 12 years of age or older who have previously received the first dose of any approved vaccine. The additional dose must be given at least 4 months after the vaccination.